Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcysteine and folate therapy for hyperhomocysteinemia in hemodialysis patients
2007-000451-34Phase 3Active
- Sponsor
- Azienda Ospedaliera Universitaria Luigi Vanvitelli
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of acetylcysteine in hyperhomocysteinemia and end-stage kidney disease (ESKD), sponsored by Azienda Ospedaliera Universitaria Luigi Vanvitelli. Primary endpoint: Reduction in plasma homocysteine levels. Started Sep 2010; status: active.
02
Drugs
acetylcysteine
03
Conditions
hyperhomocysteinemiaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2007-000451-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000451-34.